ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011